SensiQ Technologies, Inc. is the recipient of a National Institutes of Health grant to develop a next generation label-free sensing platform for drug discovery. SensiQ Technologies is expected to receive approximately $1.3 Million in total funding through Phase I and Phase II of the NIH FastTrack award program.
PRLog - Sep 17, 2013 - OKLAHOMA CITY -- SensiQ Technologies, Inc. is the recipient of a National Institutes of Health grant to develop a next generation label-free sensing platform for drug discovery.
“SensiQ Technologies has received Phase I funding from NIH to develop a next generation surface plasmon resonance-based platform,” said David Goad, PhD, Research Scientist for SensiQ Technologies and Principal Investigator for the research. "We anticipate this project will result in new, state-of-the-art SPR biosensing technology with applications in a number of research areas such as drug discovery, particularly fragment-based screening methods." SensiQ Technologies is expected to receive approximately $1.3 million in total funding through Phase I and Phase II of the NIH FastTrack award program.
“Coupled with our unique injection technologies known as diSPRTM, SensiQ Technologies will advance the state of the art in label-free drug discovery platforms”, said Tom Jobe, Chief Operating Officer.
Research reported in this press release was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, under award number R44TR000618.
About SensiQ Technologies, Inc.
SensiQ Technologies, Inc. develops and manufactures innovative tools for the advancement of life sciences research. SensiQ Technologies offers a suite of instruments and platforms for biomolecular interaction analysis using Label-Free Surface Plasmon Resonance (SPR) technologies. Additional information is available on the company’s website at: www.sensiqtech.com. The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Read Full Story - SensiQ Technologies Announces NIH Grant for Development of Next Generation Label-Free Platform | More news from this source
Press release distribution by PRLog
SensiQ Technologies Announces NIH Grant for Development of Next Generation Label-Free Platform
September 17, 2013 at 09:00 AM EDT
